SCHEMBL6180337

SCHEMBL6180337

O=S(=O)(c1ccc(F)cc1)N1CCC[C@H]1c1ccsc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.73
LMNA P02545 4/20 0.47
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
HSD17B10 Q99714 1/20 0.44
HTR7 P34969 1/20 0.43
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.42
USP2 O75604 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180330 1.00 TRPA1 (0.73) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6180550 0.87 PSEN1 (0.63) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6177953 0.87 TRPA1 (0.54) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6177949 0.87 TRPA1 (0.54) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6180546 0.87 PSEN1 (0.63) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178865 0.85 TRPA1 (1.00) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178870 0.85 TRPA1 (1.00) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6177808 0.79 TRPA1 (0.86) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6177006 0.79 TRPA1 (0.86) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL3731913 0.79 TRPA1 (0.86) TRPA1LMNAPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed